BJA FY25 DNA Capacity Enhancement for Backlog Reduction (CEBR)- Formula Grants Program
ID: 360565Type: Posted
Overview

Buyer

Bureau of Justice Assistance (USDOJ-OJP-BJA)

Award Range

$0 - $4M

Eligible Applicants

Others

Funding Category

Law, Justice and Legal Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360565

Additional Information

https://bja.ojp.gov/funding/opportunities/o-bja-2025-172460
Timeline
    Description

    The Bureau of Justice Assistance is offering the BJA FY25 DNA Capacity Enhancement for Backlog Reduction (CEBR) Formula Grants Program to support states and local government units with existing crime laboratories that conduct DNA analysis. The program aims to enhance the capacity to process more DNA samples for entry into the Combined DNA Index System (CODIS), thereby reducing the backlog of forensic DNA samples awaiting analysis. This initiative is crucial for improving the efficiency of forensic investigations and ensuring timely justice. Interested applicants can apply for grants with an award ceiling of $3,500,000, and the application deadline is October 22, 2025. For further details, applicants may contact the grantor at OJP.ResponseCenter@usdoj.gov or visit the program's webpage at https://bja.ojp.gov/funding/opportunities/o-bja-2025-172460.

    Point(s) of Contact
    OJP.ResponseCenter@usdoj.gov
    Files
    No associated files provided.
    Similar Opportunities
    OJJDP FY25 Internet Crimes Against Children On-Line Child Protection System (ICACCOPS) – Invited to Apply
    Office of Juvenile Justice Delinquency Prevention
    The Office of Juvenile Justice Delinquency Prevention (OJJDP) is inviting applications for the FY25 Internet Crimes Against Children On-Line Child Protection System (ICACCOPS) through a cooperative agreement. This initiative aims to support a national network of 61 multi-agency, multi-jurisdictional task forces that focus on investigations, forensic examinations, and prosecutions related to technology-facilitated child sexual exploitation, while also providing technical assistance and community education. The total estimated program funding is $900,000, with a single award anticipated, and applications are due by December 8, 2025. Interested applicants, specifically Fox Valley Technical College, can reach out to Aquilah Munir at Aquilah.Munir@usdoj.gov for further information.
    Elder Justice Innovation Grants FY2026
    Administration for Community Living
    The Administration for Community Living is offering the Elder Justice Innovation Grants for Fiscal Year 2026, aimed at supporting projects that address emerging issues related to elder justice. The program seeks to enhance the field of elder abuse prevention and intervention by funding initiatives that develop widely disseminable materials and programs or contribute to the evidence base of knowledge in this area. With an estimated total program funding of $3 million, the agency anticipates awarding six grants, with individual awards ranging from $250,000 to $500,000. Interested applicants can find more information and contact Kari Benson at (202) 401-4634 or via email at contactelderjustice@acl.hhs.gov, with proposals due by May 5, 2026, and project start dates expected in September 2026.
    Centers of Excellence in Genomic Science (CEGS)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Centers of Excellence in Genomic Science (CEGS) program, aimed at fostering interdisciplinary research teams to tackle significant biomedical challenges from a genomics perspective. The initiative seeks to develop innovative concepts, methods, and technologies that can lead to transformative advancements in genomic science, genomic medicine, and computational genomics, with a focus on high-risk, high-reward projects that are unlikely to be pursued through standard funding mechanisms. With an estimated total program funding of $5 million and the expectation of awarding two grants, interested applicants can reach out to Stephanie A. Morris at morriss2@mail.nih.gov or call 301-435-5738 for further information. The application process is set to open with a synopsis posting on March 25, 2026, and will close on June 24, 2026, with awards anticipated by April 1, 2027.
    Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced the Cutting-Edge Basic Research Awards (CEBRA) aimed at promoting innovative research in the field of substance use disorders (SUDs). This funding opportunity invites exploratory applications that focus on high-risk, high-impact research not currently represented in NIDA’s portfolio, encouraging the development of revolutionary methodologies or the testing of transformative hypotheses. The program seeks to stimulate novel insights into the etiology and treatment of SUDs by integrating diverse scientific disciplines, with a maximum budget of $275,000 for each two-year project, allowing no more than $150,000 to be requested in a single year. Applications are due by February 10, 2025, and the funding opportunity will remain open until August 12, 2027; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    FY 25 Fostering Access, Rights and Equity (FARE) Grant Program
    Womens Bureau
    The Women's Bureau of the Department of Labor is offering the FY 25 Fostering Access, Rights and Equity (FARE) Grant Program to support projects aimed at assisting marginalized and underserved women workers affected by gender-based violence and harassment (GBVH) in the workplace. Eligible applicants include nonprofit organizations without 501(c)(3) status that demonstrate strong community ties and the capacity to implement trauma-informed, survivor-centered strategies to address GBVH. This grant program is crucial for enhancing workplace safety and economic security for women, with a total funding pool of $1 million, awarding between $250,000 and $350,000 to an expected four recipients. Interested organizations should submit their applications electronically by June 10, 2025, and can direct inquiries to WB.OGM@dol.gov.
    Enhancing global laboratory systems to safely manage biological risks, deploy diagnostics and sequence pathogens to strengthen health protection worldwide
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at enhancing global laboratory systems to manage biological risks and improve health protection worldwide. The initiative focuses on strengthening public health laboratory systems, workforce development, bio risk management, emergency preparedness, laboratory quality management, and enhancing diagnostic capacities, particularly in low-resource settings. This funding opportunity, with an estimated total program funding of $25 million and expected to award three grants, is open to unrestricted applicants, with applications due by January 2, 2026. For further inquiries, interested parties can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Centers for Genomics Research Capacity Building
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Centers for Genomics Research Capacity Building," aimed at enhancing genomics research capabilities at biomedical institutions. This initiative seeks applications from small businesses to establish Genomic Research Centers that will support interdisciplinary teams in developing innovative genomic research projects addressing critical issues such as genomic technology, disease genomics, and the ethical implications of genomic research. With an estimated total program funding of $5 million and the expectation of awarding three grants, interested applicants are encouraged to begin forming collaborations and developing proposals, with the anticipated synopsis posting date on December 1, 2025, and a closing date for applications on March 2, 2026. For further inquiries, potential applicants can contact Jennifer Troyer at jennifer.troyer@nih.gov or by phone at 301-312-3276.
    Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity titled "Integrating Biospecimen Science Approaches into Clinical Assay Development" (FON: PAR-25-325). This initiative aims to support extramural research focused on addressing preanalytical variability in the development and analytical validation of clinical assays utilizing biospecimens such as tumor biopsies and liquid biopsies. The program seeks to enhance the reliability of biomarker assays by investigating how various collection, processing, and storage conditions impact biomarker quantification, ultimately contributing to improved cancer diagnostics and treatment in precision medicine. Interested applicants can apply for funding of up to $250,000 annually for a period of five years, with the first application deadline set for January 4, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-325.html.
    Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering a federal grant titled "Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities." This grant aims to enhance understanding of drug shortages, particularly those susceptible to health fraud, and to identify outsourcing facilities that can help meet these critical needs, thereby strengthening the drug supply chain. The funding, totaling $3 million with an award ceiling of $3 million and an expected two awards, will support research and development initiatives aimed at mitigating persistent drug shortages and stabilizing the supply of essential medications. Interested applicants can reach out to Patrick Johnson at patrick.johnson@fda.hhs.gov for further information, with the grant opportunity posted for the fiscal year 2025.
    Centers of Biomedical Research Excellence: Development Phase (COBRE-D)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Centers of Biomedical Research Excellence: Development Phase (COBRE-D)" aimed at enhancing biomedical research capacity in IDeA-eligible states. This program is designed to support institutions in these states by providing funding to recruit and mentor early-career investigators, establish research facilities, and improve research administration support services, thereby addressing the limited infrastructure and expertise in broad scientific areas of strategic importance. The COBRE-D program serves as a foundational step for less-resourced institutions to transition into the more advanced Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S) program. Interested applicants, specifically private institutions of higher education located in designated IDeA states, should note that the estimated project start date is July 1, 2027, with applications due by September 28, 2026. For further inquiries, contact Dr. Federico Bernal at federico.bernal@nih.gov or call 240-271-5059.